Literature DB >> 34927529

Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.

Gail J Roboz1, Karen Yee2, Amit Verma3, Gautam Borthakur4, Adolfo de la Fuente Burguera5, Guillermo Sanz6, Helai P Mohammad7, Ryan G Kruger7, Natalie O Karpinich7, Geraldine Ferron-Brady7, Andre Acusta7, Heather Del Buono7, Therese Collingwood7, Marc Ballas7, Arindam Dhar7, Andrew H Wei8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34927529     DOI: 10.1080/10428194.2021.2012667

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  1 in total

Review 1.  Recent Advances in Biocatalysis for Drug Synthesis.

Authors:  Alina Kinner; Philipp Nerke; Regine Siedentop; Till Steinmetz; Thomas Classen; Katrin Rosenthal; Markus Nett; Jörg Pietruszka; Stephan Lütz
Journal:  Biomedicines       Date:  2022-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.